This content is targeted at healthcare professionals and shall be used as a reference only. This material represents personal viewpoints and is intended to promote the communication and exchange of medical information. This content may contain information otherwise not accessible, approved or valid in your country. Please be aware that we do not take any responsibility for you accessing information which may not comply with any legal process, regulation, registration or usage in the country of your origin. This contentl may contain products or clinical indications that have not yet been registered or approved in your country. Please refer to the locally approved package insert for detailed prescription information or check with your local Roche representative.
Speakers
Dr. Herbert Loong
Deputy Medical Director, Phase 1 Clinical Trials Centre, The Chinese University of Hong Kong
Dr. Linda Mileshkin
Director of Medical Oncology, Peter MacCallum Cancer Centre, Australia
Dr. Sewanti Limaye
Director of Medical & Precision Oncology, Reliance Foundation Hospital & Research Center, India
Dr. Dejan Juric
Director, Termeer Center for Targeted Therapies & Investigational Cancer Therapeutics Program, Massachusetts General Hospital Cancer Centre, U.S.A.
Moderators
Dr. Daniel Chan
Senior Consultant, Medical Oncology, ICON Cancer Centre, Singapore
Dr. Yoon Sim Yap
Senior Consultant, Division of Medical Oncology, National Cancer Centre, Singapore
Agenda
Topic
Speakers
Opening and Introduction
Mr. Lance Little Head of Region Asia Pacific, Roche Diagnostics Ltd.
Trends and Challenges in Molecular Tumour Board Implementation in Asia-Pacific Region: APAC MTB Expert Consensus Statement
Dr. Herbert Loong
Unlocking the Power of Liquid Biopsy-based Profiling in Clinical Practice
Dr. Linda Mileshkin
Panel Discussion: Facilitating Access to Molecularly Guided Treatment Options by Leveraging Advancements in Genomic Profiling and Molecular Tumour Boards
Panelists: Dr. Herbert Loong Dr. Linda Mileshkin Dr. Aya Helali
Break
All
The Evolution of Comprehensive Genomic Profiling: From Lung Cancer Pioneers to Ovarian and Breast Cancer Paradigms
Dr. Sewanti Limaye
Targeting PIK3CA Mutation in Breast Cancer: From Testing to Therapeutic Strategies
Dr. Dejan Juric
Panel Discussion: Management of Novel Genes in Breast Cancer
Panelists: Dr. Dejan Juric Dr. Sewanti Limaye Dr. Pranav Dorwal
Closing
Dr. Ahmed Elhusseiny Area Head APAC, Roche Pharmaceuticals
This material represents personal viewpoint and is intended to
promote the communication and exchange of medical information, and
shall be used by healthcare professionals as a reference only.
This material may contain medicinal products or clinical
indications that have not yet been approved in your country.
Please refer to the locally approved package insert for detailed
prescription information.
Be the first to receive updates, event opportunities, and thought leadership insights.
The information contained in this website is intended for healthcare professionals only.
Click “OK” if you are a healthcare professional.
